JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Input momentum (manajer yang sebanding):
keluasan pemegang +4.0% ·
aliran saham +0.7% ·
posisi baru bersih +3.8%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.13B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (pasif) | 237.05M | — | $36.21B | 0.6% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (pasif) | 203.85M | — | $31.14B | 0.6% | n/c | 1 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (pasif) | 132.80M | -0.7% | $20.28B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 30 | Geode Capital Management ✦ (pasif) | 60.61M | +2.1% | $9.23B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 31 | Geode Capital Management ✦ (pasif) | 60.61M | +2.1% | $9.23B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 32 | Norges Bank ✦ (pasif) | 31.93M | +3.6% | $4.88B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 24.88M | +9.8% | $3.80B | 0.7% | ▲ Add | 5 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 43 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 13.42M | — | $2.05B | 0.1% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 8.38M | -17.1% | $1.28B | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 8.38M | -17.1% | $1.28B | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 49 | Fisher Asset Management ✦ | 8.27M | -5.0% | $1.26B | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 56 | AQR Capital Management ✦ | 4.80M | -8.9% | $728.72M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 57 | D. E. Shaw & Co. ✦ | 2.85M | +142.4% | $434.70M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 58 | D. E. Shaw & Co. ✦ | 2.85M | +142.4% | $434.70M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 59 | Arrowstreet Capital ✦ | 2.46M | -25.5% | $375.64M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 60 | Bridgewater Associates ✦ | 2.28M | +667.8% | $348.66M | 1.4% | ▲ Add | 5 | SEC ↗ |
| 61 | Marshall Wace ✦ | 1.58M | +73.5% | $241.89M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 62 | Marshall Wace ✦ | 1.58M | +73.5% | $241.89M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 63 | Marshall Wace ✦ | 1.58M | +73.5% | $241.89M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 64 | Adage Capital Partners ✦ | 1.34M | +4.5% | $204.16M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 65 | Millennium Management ✦ | 1.05M | -16.1% | $160.80M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 66 | Renaissance Technologies ✦ | 883.19K | +336.0% | $134.91M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 67 | Markel Group ✦ | 610.80K | 0.0% | $93.30M | 0.8% | Held | 5 | SEC ↗ |
| 68 | Markel Group ✦ | 610.80K | 0.0% | $93.30M | 0.8% | Held | 5 | SEC ↗ |
| 69 | Point72 Asset Management ✦ | 583.76K | Baru | $89.17M | 0.2% | New | 1 | SEC ↗ |
| 70 | Citadel Advisors ✦ | 557.44K | -16.1% | $85.15M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 71 | Citadel Advisors ✦ | 557.44K | -16.1% | $85.15M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 72 | Tweedy, Browne ✦ | 244.71K | -44.2% | $37.38M | 3.5% | ▼ Trim | 5 | SEC ↗ |
| 73 | Gotham Asset Management ✦ | 184.35K | +87.3% | $28.16M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 74 | Two Sigma Investments ✦ | 176.99K | +638.8% | $27.04M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 75 | GAMCO Investors ✦ | 86.58K | -0.1% | $13.23M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 76 | Fairfax Financial ✦ | 73.40K | 0.0% | $11.20M | 0.6% | Held | 5 | SEC ↗ |
| 77 | Dodge & Cox ✦ | 20.95K | -0.7% | $3.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $89.17M | 0.2% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 136.10K saham, $33,268 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 15.00K lbr · $3.95M
Officer, Director · 20.98K lbr · $5.50M
Officer, Director · 102.31K lbr · $26.70M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a…
Reuters